Skip to main content
OpenTrials
Completed

NCT Number: NCT05970328

Hexoskin Medical System - ECG Performance Testing

The goal of this observational study is to validate the efficacy of the Hexoskin Medical System (HMS) for its intended use (i.e., manual assessment of cardiac rhythm disturbances) in non-critical adult participants who are suspected of having an arrhythmia or have evidence of arrhythmia requiring monitoring via 24-hour Holter monitor.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Lawrence Park Cardiology, Toronto, Ontario, Canada

Loading trial locations.

About this study

The main questions it aims to answer are:

  • Whether the HMS ECG recordings can be used to accurately detect cardiac beats when compared with the Holter monitor
  • Whether there are good agreements between the HMS and Holter monitor in ECG characteristics
  • Whether the HMS ECG recordings can be used to accurately classify cardiac rhythm/rhythm disturbance when compared with the Holter monitor
  • What is the accuracy of using HMS ECG recordings to detect cardiac beats
  • What is the accuracy of using HMS ECG recordings to identify cardiac rhythm/rhythm disturbance

Participants will wear the HMS and the Holter monitor at the same time to record ECG signals. Researchers will evaluate the ECG recordings acquired from both devices and assess the above questions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Provision of signed and dated informed consent form.
  • Stated willingness to comply with all study procedures and availability for the duration of the study.
  • Male or female, aged 21 years or older.
  • Participants must be suspected of having an arrhythmia or have evidence of arrhythmia requiring monitoring via 24-hour Holter monitor.

Exclusion criteria

  • Body circumference that is not covered by the HMS Shirt sizing chart
  • Presence of pacemaker or Implantable Cardioverter-Defibrillator (ICD) devices
  • Known allergic reactions to silver or polyamide/polyester/elastane
  • Known allergic reactions to ECG gel electrodes
  • Documented medical condition or illness requiring intensive medical treatment or care

Treatment and study plan

Hexoskin Medical System

Device

Participant wears both the Hexoskin Medical System and the Nasiff Holter Monitor at the same time to acquire ECG recordings.

Other names: Nasiff Holter Monitor

Primary outcomes

  1. ECG characteristics measurement agreement

    Time frame: 2 days

    The agreement (Bland-Altman plots) of Holter monitor(reference standard) and HMS to measure each of the four (4) ECG Characteristics. ECG characteristics measured in this study include: RR Interval (ms), PR Interval (ms), PP Interval (ms), and QRS Duration (ms).

Secondary outcomes

  1. Heart rate agreement

    Time frame: 2 days

    The agreement between HR calculated from the recordings acquired by the subject device and the reference Holter monitor.

Other outcomes

  1. Cardiac beat detection accuracy

    Time frame: 2 days

    The sensitivity and PPV of using the subject device recordings to detect cardiac beats.

  2. Rhythm identification accuracy

    Time frame: 2 days

    The sensitivity and PPV of using the subject recordings to identify cardiac rhythm/rhythm disturbances.

  3. ECG recording stability

    Time frame: 2 days

    The stability of the subject device for recording ECG through 24 hours of ambulatory ECG monitoring.

Sponsors and collaborators

Lead sponsor

Carré Technologies Inc.

Industry

Registry information

Official study title

HMS ECG Clinical Validation Study - Protocol External Site

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Aug 1, 2023
Registry last updated
Aug 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.